Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease

✍ Scribed by Daniel Murrey; Michael Janssen; Rick Delamarter; Jeffrey Goldstein; Jack Zigler; Bobby Tay; Bruce Darden

• Book ID: 119370916
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 429 KB
• Volume: 9
• Category: Article
• ISSN: 1529-9430
• DOI: 10.1016/j.spinee.2008.05.006